Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6
- 20 February 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 29 (7) , 1899-1906
- https://doi.org/10.1021/bi00459a034
Abstract
NAD(P)H:quinone oxidoreductases (NQOs) are flavoproteins that catalyze the oxidation of NADH or NADPH by various quinones and oxidation-reduction dyes. We have previously described a complementary DNA that encodes a dioxin-inducible cytosolic form of human NAD(P)H:quinone oxidoreductase (NQO1). In the present report we describe the nucleotide sequence and deduced amino acid sequence for a cDNA clone that is likely to encode a second form of NAD(P)H:quinone oxidoreductase (NQO2) which was isolated by screening a human liver cDNA library by hybridization with a NQO1 cDNA probe. The NQO2 cDNA is 976 nucleotides long and encodes a protein of 231 amino acids (Mr = 25,956). The human NQO2 cDNA and protein are 54% nd 49% similar to human liver cytosolic NQO1 cDNA and protein, respectively. COS1 cells transfected with NQO2 cDNA showed a 5-7-fold increase in NAD-(P)H:quinone oxidoreductase activity as compared to nontransfected cells when either 2,6-dichlorophenolindophenol or menadione was used as substrate. Western blot analysis of the expressed NQO1 and NQO2 cDNA proteins showed cross-reactivity with rat NQO1 antiserum, indicating tht NQO1 and NQO2 proteins are immunologically related. Northern blot analysis shows the presence of one NQO2 mRNA of 1.2 kb in control and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treated human hepatoblastoma Hep-G2 cells and that TCDD treatment does not lead to enhanced levels of NQO2 mRNA as it does for NQO1 mRNA. Southern blot analysis of human genomic DNA suggests the presence of a single gene approximately 14-17 kb in length. The NQO2 gene locus is highly polymorphic as indicated by several restriction fragment length polymorphisms detected with five different restriction enzymes. The NQO2 gene was localized to human chromosome 6 by Southern analysis of human-rodent somatic cell hybrids. Further analysis of several hybrids containing breaks or translocations involving chromosome 6 allowed regional localization of the NQO2 gene to chromosome 6pter-q12.This publication has 20 references indexed in Scilit:
- DT-diaphorase as a quinone reductase: A cellular control device against semiquinone and superoxide radical formationArchives of Biochemistry and Biophysics, 1982
- Cloning of DNA complementary to rat liver NADPH-cytochrome c (P-450) oxidoreductase and cytochrome P-450b mRNAs. Evidence that phenobarbital augments transcription of specific genes.Journal of Biological Chemistry, 1982
- Chromosomal location of human kappa and lambda immunoglobulin light chain constant region genesThe Journal of Experimental Medicine, 1982
- Biospecific adsorption of hepatic DT-diaphorase on immobilized dicoumarolArchives of Biochemistry and Biophysics, 1981
- Human FAD-dependent NAD(P)H diaphoraseBiochemical Journal, 1980
- Immunochemical studies on two DT diaphorase active antigens isolated from rat liver cytosol by affinity chromatographyArchives of Biochemistry and Biophysics, 1980
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977
- An interpretation of human diaphorase isozymes in terms of three gene loci DIA1, DIA2 and DIA3Annals of Human Genetics, 1977